Barclays PLC
22 February 2007
22 February 2007
Barclays PLC
Director/PDMR shareholding: Disclosure and Transparency Rules
3.1.4R(1)(a) and 3.1.4R(1)(b)
On 21 February 2007 the following ordinary shares in Barclays PLC were purchased
on behalf of the following non-executive directors of Barclays PLC at a price of
785.00p per share. As disclosed in the Barclays Annual Report, these purchases
arise from the policy of using part of each director's fee to purchase shares in
Barclays PLC on the directors' behalf which, together with reinvested dividends,
are retained for the director until they leave the Board.
DIRECTOR BARCLAYS PLC TOTAL BENEFICIAL TOTAL NON-BENEFICIAL
SHARES INTEREST INTEREST FOLLOWING
PURCHASED FOLLOWING THIS THIS NOTIFICATION
NOTIFICATION
Marcus Agius 427 15,427 -
Sir Richard Broadbent 806 8,898 -
Leigh Clifford 763 5,982 -
Fulvio Conti 732 3,270 -
Dr Danie Cronje 767 4,314 -
Professor Sandra Dawson 856 10,809 -
Sir Andrew Likierman 786 6,227 -
Sir Nigel Rudd 940 52,057 -
Stephen Russell 917 19,578 -
Sir John Sunderland 748 10,802 -
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.